000292565 001__ 292565
000292565 005__ 20250328112421.0
000292565 0247_ $$2doi$$a10.1038/s41698-024-00689-5
000292565 0247_ $$2pmid$$apmid:39237753
000292565 037__ $$aDKFZ-2024-01806
000292565 041__ $$aEnglish
000292565 082__ $$a610
000292565 1001_ $$0P:(DE-He78)79862c68074f8d78156f06f6e3c9801c$$aFan, Ziwen$$b0$$eFirst author$$udkfz
000292565 245__ $$aDeveloping survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood.
000292565 260__ $$a[London]$$bSpringer Nature$$c2024
000292565 3367_ $$2DRIVER$$aarticle
000292565 3367_ $$2DataCite$$aOutput Types/Journal article
000292565 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1727684230_26628
000292565 3367_ $$2BibTeX$$aARTICLE
000292565 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000292565 3367_ $$00$$2EndNote$$aJournal Article
000292565 500__ $$a#EA:C070#LA:C070#LA:C120#
000292565 520__ $$aWhile genome-wide association studies are valuable in identifying CRC survival predictors, the benefit of adding blood DNA methylation (blood-DNAm) to clinical features, including the TNM system, remains unclear. In a multi-site population-based patient cohort study of 2116 CRC patients with baseline blood-DNAm, we analyzed survival predictions using eXtreme Gradient Boosting with a 5-fold nested leave-sites-out cross-validation across four groups: traditional and comprehensive clinical features, blood-DNAm, and their combination. Model performance was assessed using time-dependent ROC curves and calibrations. During a median follow-up of 10.3 years, 1166 patients died. Although blood-DNAm-based predictive signatures achieved moderate performances, predictive signatures based on clinical features outperformed blood-DNAm signatures. The inclusion of blood-DNAm did not improve survival prediction over clinical features. M1 stage, age at blood collection, and N2 stage were the top contributors. Despite some prognostic value, incorporating blood DNA methylation did not enhance survival prediction of CRC patients beyond clinical features.
000292565 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000292565 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000292565 7001_ $$0P:(DE-He78)92820b4867c955a04f642707ecf35b40$$aEdelmann, Dominic$$b1$$udkfz
000292565 7001_ $$0P:(DE-He78)b9e439a1aa1244925f92d547c0919349$$aYuan, Tanwei$$b2$$udkfz
000292565 7001_ $$aKöhler, Bruno Christian$$b3
000292565 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b4$$udkfz
000292565 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$eLast author$$udkfz
000292565 773__ $$0PERI:(DE-600)2891458-2$$a10.1038/s41698-024-00689-5$$gVol. 8, no. 1, p. 191$$n1$$p191$$tnpj precision oncology$$v8$$x2397-768X$$y2024
000292565 8564_ $$uhttps://inrepo02.dkfz.de/record/292565/files/s41698-024-00689-5.pdf
000292565 8564_ $$uhttps://inrepo02.dkfz.de/record/292565/files/s41698-024-00689-5.pdf?subformat=pdfa$$xpdfa
000292565 8767_ $$8SN-2024-01444-b$$92025-12-05$$d2025-03-27$$eAPC$$jZahlung erfolgt
000292565 909CO $$ooai:inrepo02.dkfz.de:292565$$pVDB$$pOpenAPC$$popenCost
000292565 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79862c68074f8d78156f06f6e3c9801c$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000292565 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)92820b4867c955a04f642707ecf35b40$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000292565 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b9e439a1aa1244925f92d547c0919349$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000292565 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000292565 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000292565 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000292565 9141_ $$y2024
000292565 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNPJ PRECIS ONCOL : 2022$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T15:13:05Z
000292565 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T15:13:05Z
000292565 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-04-12T15:13:05Z
000292565 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-04-12T15:13:05Z
000292565 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNPJ PRECIS ONCOL : 2022$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-10-27
000292565 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-10-27
000292565 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
000292565 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
000292565 915pc $$0PC:(DE-HGF)0002$$2APC$$aDFG OA Publikationskosten
000292565 915pc $$0PC:(DE-HGF)0003$$2APC$$aDOAJ Journal
000292565 9202_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000292565 9202_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000292565 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000292565 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x1
000292565 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000292565 9200_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000292565 980__ $$ajournal
000292565 980__ $$aVDB
000292565 980__ $$aI:(DE-He78)C070-20160331
000292565 980__ $$aI:(DE-He78)C060-20160331
000292565 980__ $$aI:(DE-He78)HD01-20160331
000292565 980__ $$aUNRESTRICTED
000292565 980__ $$aAPC